Literature DB >> 21389128

Open reading frames carried on UL/b' are implicated in shedding and horizontal transmission of rhesus cytomegalovirus in rhesus monkeys.

Kristie L Oxford1, Lisa Strelow, Yujuan Yue, W L William Chang, Kimberli A Schmidt, Don J Diamond, Peter A Barry.   

Abstract

Implicit with the use of animal models to test human cytomegalovirus (HCMV) vaccines is the assumption that the viral challenge of vaccinated animals reflects the anticipated virus-host interactions following exposure of vaccinated humans to HCMV. Variables of animal vaccine studies include the route of exposure to and the titer of challenge virus, as well as the genomic coding content of the challenge virus. This study was initiated to provide a better context for conducting vaccine trials with nonhuman primates by determining whether the in vivo phenotype of culture-passaged strains of rhesus cytomegalovirus (RhCMV) is comparable to that of wild-type RhCMV (RhCMV-WT), particularly in relation to the shedding of virus into bodily fluids and the potential for horizontal transmission. Results of this study demonstrate that two strains containing a full-length UL/b' region of the RhCMV genome, which encodes proteins involved in epithelial tropism and immune evasion, were persistently shed in large amounts in bodily fluids and horizontally transmitted, whereas a strain lacking a complete UL/b' region was not shed or transmitted to cagemates. Shedding patterns exhibited by strains encoding a complete UL/b' region were consistent with patterns observed in naturally infected monkeys, the majority of whom persistently shed high levels of virus in saliva for extended periods of time after seroconversion. Frequent viral shedding contributed to a high rate of infection, with RhCMV-infected monkeys transmitting virus to one naïve animal every 7 weeks after introduction of RhCMV-WT into an uninfected cohort. These results demonstrate that the RhCMV model can be designed to rigorously reflect the challenges facing HCMV vaccine trials, particularly those related to horizontal transmission.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21389128      PMCID: PMC3126184          DOI: 10.1128/JVI.02631-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  79 in total

1.  Evolutionarily divergent herpesviruses modulate T cell activation by targeting the herpesvirus entry mediator cosignaling pathway.

Authors:  Timothy C Cheung; Ian R Humphreys; Karen G Potter; Paula S Norris; Heather M Shumway; Bonnie R Tran; Ginelle Patterson; Rochelle Jean-Jacques; Miri Yoon; Patricia G Spear; Kenneth M Murphy; Nell S Lurain; Chris A Benedict; Carl F Ware
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-30       Impact factor: 11.205

2.  Genomic sequence of rhesus cytomegalovirus 180.92: insights into the coding potential of rhesus cytomegalovirus.

Authors:  Pierre Rivailler; Amitinder Kaur; R Paul Johnson; Fred Wang
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

3.  Human cytomegalovirus entry into epithelial and endothelial cells depends on genes UL128 to UL150 and occurs by endocytosis and low-pH fusion.

Authors:  Brent J Ryckman; Michael A Jarvis; Derek D Drummond; Jay A Nelson; David C Johnson
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

4.  Role of human cytomegalovirus UL131A in cell type-specific virus entry and release.

Authors:  Barbara Adler; Laura Scrivano; Zsolt Ruzcics; Brigitte Rupp; Christian Sinzger; Ulrich Koszinowski
Journal:  J Gen Virol       Date:  2006-09       Impact factor: 3.891

5.  Deletion of gpUL132, a structural component of human cytomegalovirus, results in impaired virus replication in fibroblasts.

Authors:  Simone Spaderna; Barbara Kropff; Yvonne Ködel; Siyuan Shen; Scott Coley; Shan Lu; William Britt; Michael Mach
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

6.  Immunogenicity and protective efficacy of DNA vaccines expressing rhesus cytomegalovirus glycoprotein B, phosphoprotein 65-2, and viral interleukin-10 in rhesus macaques.

Authors:  Yujuan Yue; Amitinder Kaur; Meghan K Eberhardt; Nadine Kassis; Shan Shan Zhou; Alice F Tarantal; Peter A Barry
Journal:  J Virol       Date:  2006-11-15       Impact factor: 5.103

7.  Human cytomegalovirus virion protein complex required for epithelial and endothelial cell tropism.

Authors:  Dai Wang; Thomas Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-30       Impact factor: 11.205

8.  Characterization and immunological analysis of the rhesus cytomegalovirus homologue (Rh112) of the human cytomegalovirus UL83 lower matrix phosphoprotein (pp65).

Authors:  Yujuan Yue; Amitinder Kaur; Shan Shan Zhou; Peter A Barry
Journal:  J Gen Virol       Date:  2006-04       Impact factor: 3.891

9.  Temple monkeys and health implications of commensalism, Kathmandu, Nepal.

Authors:  Lisa Jones-Engel; Gregory A Engel; John Heidrich; Mukesh Chalise; Narayan Poudel; Raphael Viscidi; Peter A Barry; Jonathan S Allan; Richard Grant; Randy Kyes
Journal:  Emerg Infect Dis       Date:  2006-06       Impact factor: 6.883

10.  Human cytomegalovirus encodes an MHC class I-like molecule (UL142) that functions to inhibit NK cell lysis.

Authors:  Mark R Wills; Omodele Ashiru; Matthew B Reeves; Georgina Okecha; John Trowsdale; Peter Tomasec; Gavin W G Wilkinson; John Sinclair; J G Patrick Sissons
Journal:  J Immunol       Date:  2005-12-01       Impact factor: 5.422

View more
  34 in total

1.  Maternal CD4+ T cells protect against severe congenital cytomegalovirus disease in a novel nonhuman primate model of placental cytomegalovirus transmission.

Authors:  Kristy M Bialas; Takayuki Tanaka; Dollnovan Tran; Valerie Varner; Eduardo Cisneros De La Rosa; Flavia Chiuppesi; Felix Wussow; Lisa Kattenhorn; Sheila Macri; Erika L Kunz; Judy A Estroff; Jennifer Kirchherr; Yujuan Yue; Qihua Fan; Michael Lauck; David H O'Connor; Allison H S Hall; Alvarez Xavier; Don J Diamond; Peter A Barry; Amitinder Kaur; Sallie R Permar
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-19       Impact factor: 11.205

2.  Neutralization of rhesus cytomegalovirus IL-10 reduces horizontal transmission and alters long-term immunity.

Authors:  Jesse D Deere; W L William Chang; Andradi Villalobos; Kimberli A Schmidt; Ashlesha Deshpande; Luis D Castillo; Joseph Fike; Mark R Walter; Peter A Barry; Dennis J Hartigan-O'Connor
Journal:  Proc Natl Acad Sci U S A       Date:  2019-06-12       Impact factor: 11.205

3.  Plasmablast Response to Primary Rhesus Cytomegalovirus (CMV) Infection in a Monkey Model of Congenital CMV Transmission.

Authors:  Qihua Fan; Cody S Nelson; Kristy M Bialas; Flavia Chiuppesi; Joshua Amos; Thaddeus C Gurley; Dawn Jones Marshall; Joshua Eudailey; Holly Heimsath; Jonathon Himes; Ashlesha Deshpande; Mark R Walter; Felix Wussow; Don J Diamond; Peter A Barry; M Anthony Moody; Amitinder Kaur; Sallie R Permar
Journal:  Clin Vaccine Immunol       Date:  2017-05-05

4.  Exploitation of Interleukin-10 (IL-10) Signaling Pathways: Alternate Roles of Viral and Cellular IL-10 in Rhesus Cytomegalovirus Infection.

Authors:  Meghan K Eberhardt; Ashlesha Deshpande; Joseph Fike; Rebecca Short; Kimberli A Schmidt; Shelley A Blozis; Mark R Walter; Peter A Barry
Journal:  J Virol       Date:  2016-10-14       Impact factor: 5.103

5.  Reevaluation of the coding potential and proteomic analysis of the BAC-derived rhesus cytomegalovirus strain 68-1.

Authors:  Daniel Malouli; Ernesto S Nakayasu; Kasinath Viswanathan; David G Camp; W L William Chang; Peter A Barry; Richard D Smith; Klaus Früh
Journal:  J Virol       Date:  2012-06-20       Impact factor: 5.103

6.  Developing a Vaccine against Congenital Cytomegalovirus (CMV) Infection: What Have We Learned from Animal Models? Where Should We Go Next?

Authors:  Mark R Schleiss
Journal:  Future Virol       Date:  2013-12       Impact factor: 1.831

7.  Coding potential of UL/b' from the initial source of rhesus cytomegalovirus Strain 68-1.

Authors:  Rachel B Gill; J Jason Bowman; Tammy Krogmann; Kurt Wollenberg; David M Asher; Jeffrey I Cohen
Journal:  Virology       Date:  2013-10-02       Impact factor: 3.616

8.  Identification and Functional Characterization of a Novel Fc Gamma-Binding Glycoprotein in Rhesus Cytomegalovirus.

Authors:  Philipp Kolb; Steven Sijmons; Matthew R McArdle; Husam Taher; Jennie Womack; Colette Hughes; Abigail Ventura; Michael A Jarvis; Christiane Stahl-Hennig; Scott Hansen; Louis J Picker; Daniel Malouli; Hartmut Hengel; Klaus Früh
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

9.  A vaccine based on the rhesus cytomegalovirus UL128 complex induces broadly neutralizing antibodies in rhesus macaques.

Authors:  Felix Wussow; Yujuan Yue; Joy Martinez; Jesse D Deere; Jeff Longmate; Andreas Herrmann; Peter A Barry; Don J Diamond
Journal:  J Virol       Date:  2012-11-14       Impact factor: 5.103

10.  The susceptibility of primary cultured rhesus macaque kidney epithelial cells to rhesus cytomegalovirus strains.

Authors:  Yujuan Yue; Amitinder Kaur; Anders Lilja; Don J Diamond; Mark R Walter; Peter A Barry
Journal:  J Gen Virol       Date:  2016-03-14       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.